# RESERPINE, HYDROCHLOROTHIAZIDE, AND HYDRALAZINE HYDROCHLORIDE
> **ANDA087709** · Abbreviated New Drug Application (Generic) · Sponsor: LEDERLE · Approved 1983-09-07
## Drug
- **FDA Application Number:** ANDA087709
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RESERPINE, HYDROCHLOROTHIAZIDE, AND HYDRALAZINE HYDROCHLORIDE
- **Generic name:** Hydralazine Hydrochloride
- **Active ingredients:** HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** LEDERLE
- **First approval:** 1983-09-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=087709)
---
*MORVS · CC0 1.0*